ArticleJournal of the Royal Statistical Society. Series A, (Statistics in Society)2025
Integrating testing volume into bandit algorithms for infectious disease surveillance.
Article in Journal of the Royal Statistical Society. Series A, (Statistics in Society), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Mobile testing services provide opportunities for active surveillance of infectious diseases for hard-to-reach and/or high-risk individuals who do not know their disease status. Identifying as many infected individuals as possible is important for mitigating disease transmission. Recently, multi-armed bandit sampling approaches have been adapted and applied in this setting to maximize the cumulative number of positive tests collected over time. However, these algorithms have not considered the possibility of variability in the number of tests administered across testing sites. What impact this variability has on the ability of these approaches to maximize yield is currently unknown. Therefore, we investigate this question by extending existing sampling frameworks to directly account for variability in testing volume while also maintaining the computational tractability of the previous methods. Through a simulation study based on human immunodeficiency virus infection characteristics in the Republic of the Congo (Congo-Brazzaville) as well as an application to COVID-19 testing data in Connecticut, we find improved long- and short-term performances of the new methods compared to several existing approaches. Based on these findings and the ease of computation, we recommend use of the newly developed methods for active surveillance of infectious diseases when variability in testing volume may be present.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.